Related references
Note: Only part of the references are listed.miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma
Nijiro Nohata et al.
Oncotarget (2015)
Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma
N. Nohata et al.
BRITISH JOURNAL OF CANCER (2011)
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
H. Yoshino et al.
BRITISH JOURNAL OF CANCER (2011)
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
James W. F. Catto et al.
EUROPEAN UROLOGY (2011)
The miR-15a-miR-16-1 Locus is Homozygously Deleted in a Subset of Prostate Cancers
Kati P. Porkka et al.
GENES CHROMOSOMES & CANCER (2011)
Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia
Kumudha Balakrishnan et al.
BLOOD (2010)
The functional significance of microRNA-145 in prostate cancer
M. S. Zaman et al.
BRITISH JOURNAL OF CANCER (2010)
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
T. Chiyomaru et al.
BRITISH JOURNAL OF CANCER (2010)
Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis
Yanbin Zhang et al.
CANCER SCIENCE (2010)
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
R. I. Aqeilan et al.
CELL DEATH AND DIFFERENTIATION (2010)
Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells
Prakash K. Rao et al.
FASEB JOURNAL (2010)
Forodesine: review of preclinical and clinical data
Aref Al-Kali et al.
FUTURE ONCOLOGY (2010)
miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma
Masayuki Kano et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Silencing Human Cancer: Identification and Uses of MicroRNAs
Francisco E. Nicolas et al.
Recent Patents on Anti-Cancer Drug Discovery (2010)
Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states
Aaron L. Sarver et al.
BMC CANCER (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
The Galanin Signaling Cascade is a Candidate Pathway Regulating Oncogenesis in Human Squamous Cell Carcinoma
Takashi Sugimoto et al.
GENES CHROMOSOMES & CANCER (2009)
Identification of novel microRNA targets based on microRNA signatures in bladder cancer
Takahiro Ichimi et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development
Dongsheng Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis
Matthew R. Cooperberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Towards the definition of prostate cancer-related microRNAs: where are we now?
Paolo Gandellini et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Cognitive effects of hormone therapy in men with prostate cancer
Christian J. Nelson et al.
CANCER (2008)
Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling
Thian-Sze Wong et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
被撤回的出版物: Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer SUPPRESSION OF TUMORIGENIC PROPERTY OF LUNG CANCER CELLS AND THEIR SENSITIZATION TO DOXORUBICIN-INDUCED APOPTOSIS BY miR-1 (Retracted article. See vol. 293, pg. 12945, 2018)
Mohd W. Nasser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Desiree Bonci et al.
NATURE MEDICINE (2008)
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
Witold Filipowicz et al.
NATURE REVIEWS GENETICS (2008)
Chimiothérapies du cancer de prostate métastatique hormonoréfractaire ou hormonorésistant
M.-O. Timsit et al.
PROGRES EN UROLOGIE (2008)
Widespread deregulation of microRNA expression in human prostate cancer
M. Ozen et al.
ONCOGENE (2008)
MicroRNA expression profiling in prostate cancer
Kati P. Porkka et al.
CANCER RESEARCH (2007)
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
A. E. Szafranska et al.
ONCOGENE (2007)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma
Farhad Ravandi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy
Tateki Yoshino et al.
CLINICAL CANCER RESEARCH (2006)
Myogenic factors that regulate expression of muscle-specific, microRNAs
Prakash K. Rao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Prostate cancer management: (2) an update on locally advanced and metastatic disease
SRJ Bott et al.
POSTGRADUATE MEDICAL JOURNAL (2003)
Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor - BCX-1777
S Bantia et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Mitochondrial basis for immune deficiency: Evidence from purine nucleoside phosphorylase-deficient mice
E Arpaia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
